Stock Yards Bank & Trust Co. Takes $203,000 Position in DENTSPLY SIRONA Inc (XRAY)
Stock Yards Bank & Trust Co. acquired a new stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 3,084 shares of the medical instruments supplier’s stock, valued at approximately $203,000.
Several other hedge funds have also added to or reduced their stakes in XRAY. Bessemer Group Inc. boosted its holdings in shares of DENTSPLY SIRONA by 4,638.6% in the 3rd quarter. Bessemer Group Inc. now owns 1,903,596 shares of the medical instruments supplier’s stock valued at $113,855,000 after acquiring an additional 1,863,424 shares during the last quarter. Alyeska Investment Group L.P. boosted its holdings in shares of DENTSPLY SIRONA by 223.7% in the 3rd quarter. Alyeska Investment Group L.P. now owns 2,271,534 shares of the medical instruments supplier’s stock valued at $135,860,000 after acquiring an additional 1,569,746 shares during the last quarter. Jackson Square Partners LLC boosted its holdings in shares of DENTSPLY SIRONA by 15.6% in the 3rd quarter. Jackson Square Partners LLC now owns 6,334,906 shares of the medical instruments supplier’s stock valued at $378,890,000 after acquiring an additional 855,199 shares during the last quarter. Parnassus Investments CA boosted its holdings in shares of DENTSPLY SIRONA by 62.7% in the 3rd quarter. Parnassus Investments CA now owns 2,115,000 shares of the medical instruments supplier’s stock valued at $126,498,000 after acquiring an additional 815,000 shares during the last quarter. Finally, Balyasny Asset Management LLC boosted its holdings in shares of DENTSPLY SIRONA by 415.5% in the 2nd quarter. Balyasny Asset Management LLC now owns 800,937 shares of the medical instruments supplier’s stock valued at $51,933,000 after acquiring an additional 645,564 shares during the last quarter. 96.14% of the stock is currently owned by institutional investors and hedge funds.
Shares of DENTSPLY SIRONA Inc (NASDAQ XRAY) traded down $2.69 during midday trading on Thursday, reaching $62.76. 4,330,500 shares of the company were exchanged, compared to its average volume of 1,962,071. DENTSPLY SIRONA Inc has a 12-month low of $52.53 and a 12-month high of $68.98. The stock has a market capitalization of $14,410.00, a P/E ratio of -18.03, a PEG ratio of 2.49 and a beta of 1.31. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.32 and a quick ratio of 1.59.
The company also recently declared a quarterly dividend, which will be paid on Friday, January 12th. Investors of record on Friday, December 29th will be issued a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 0.56%. The ex-dividend date of this dividend is Thursday, December 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.06%.
XRAY has been the topic of several recent research reports. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, October 30th. Cleveland Research downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a report on Thursday, October 5th. BidaskClub downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a report on Saturday, December 2nd. HC Wainwright reaffirmed a “buy” rating and issued a $68.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, October 3rd. Finally, Robert W. Baird set a $63.00 price target on shares of DENTSPLY SIRONA and gave the stock a “buy” rating in a report on Thursday, October 19th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $69.15.
In related news, CFO Nicholas W. Alexos acquired 50,000 shares of the firm’s stock in a transaction on Monday, November 13th. The shares were acquired at an average cost of $65.85 per share, with a total value of $3,292,500.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Eric Brandt sold 6,409 shares of the stock in a transaction on Monday, January 8th. The shares were sold at an average price of $68.04, for a total transaction of $436,068.36. Following the transaction, the director now directly owns 12,073 shares in the company, valued at $821,446.92. The disclosure for this sale can be found here. Corporate insiders own 1.99% of the company’s stock.
WARNING: This story was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://www.thecerbatgem.com/2018/01/11/stock-yards-bank-trust-co-takes-203000-position-in-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Stock Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related stocks with our FREE daily email newsletter.